GeneNews Limited announced the appointment of David Byram as the Chief Commercial Officer for its U.S. Lab, Innovative Diagnostic Laboratory, LLP. Mr. Byram will oversee all IDL's customer-facing activities including sales, client relations and commercial operations. Mr. Byram is a senior commercial executive with over 25 years of pharmaceutical, biotechnology and medical device industry leadership experience. He has built successful product launches across multiple therapeutic areas that incorporate innovative sales and marketing strategies which have driven wide market adoption and revenue generation. Prior to joining IDL, Mr. Byram was the Vice President, Commercial & Government Affairs for Braeburn Pharmaceuticals.